Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer

Ray-Coquard, I; Pautier, P; Pignata, S; Pérol, D; González-Martín, A; Berger, R; Fujiwara, K; Vergote, I; Colombo, N; Mäenpää, J; Selle, F; Sehouli, J; Lorusso, D; Guerra Alía, Em; Reinthaller, A; Nagao, S; Lefeuvre-Plesse, C; Canzler, U; Scambia, G; Lortholary, A; Marmé, F; Combe, P; de Gregorio, N; Rodrigues, M; Buderath, P; Dubot, C; Burges, A; You, B; Pujade-Lauraine, E; Harter, P; PAOLA-1, Investigators.